| Literature DB >> 31324269 |
Saba Jalalifar1, Seyed Asghar Havaei1, Tahereh Motallebirad1, Sharareh Moghim1, Hossein Fazeli1, Bahram Nasr Esfahani2.
Abstract
OBJECTIVES: Group B Streptococcus (GBS) is an important opportunistic bacteria that causes a wide range of infections including neonatal sepsis, meningitis, pneumonia, soft tissue and urinary tract infections (UTI). The aim of this study was to evaluate the antimicrobial susceptibility patterns, surface proteins and capsular types of GBS isolates.Entities:
Keywords: Antibiotic resistance; Group B Streptococci; Multiplex PCR; Surface protein; Urinary tract infection
Year: 2019 PMID: 31324269 PMCID: PMC6642507 DOI: 10.1186/s13104-019-4428-4
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Distribution of the capsular types and alp genes among the urinary GBS isolates
| Surface alpha-like protein genes | No. of isolates (%) of serotypes | ||||||
|---|---|---|---|---|---|---|---|
| Ia | Ib | II | III | IV | V | NT | |
n = 40 (%) | 2 (5) | 0** | 2 (5) | 34 (85) ** | – | 1 (2.5) ** | 1 (2.5) |
n = 22 (%) | – | 18 (81.8) ** | 1 (4.5) | 0** | – | 3 (13.6) | – |
n = 18 (%) | – | 3 (16.7) | 1 (5.6) | 6 (33.3) | 1 (5.6) | 7 (38.9) * | – |
n = 15 (%) | 2 (13.3) * | 0* | 3 (20) * | 0** | 1 (6.7) | 6 (40) * | 3** (20) |
n = 0 (%) | – | – | – | – | – | – | – |
n = 3 (%) | – | 2 (66.6) | – | – | – | 1 (33.3) | – |
n = 1 (%) | – | – | – | 1 (100) | – | – | – |
NT n = 1 (%) | – | 1 (100) | – | – | – | – | – |
* p < 0.05
** p < 0.01
Distribution of serotype and alp genes among urinary GBS isolates across resistant isolates
| Serotype | No. of resistant isolates (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Penicillin n = 8 (%) | Erythromycin n = 52 (%) | Clindamycin n = 47 (%) | Tetracycline n = 95 (%) | Vancomycin n = 1 (%) | Levofloxacin n = 9 (%) | Cefotaxime n = 8 (%) | Ceftriaxone n = 8 (%0 | Cefepime n = 8 (%) | |
|
| – | 2 (3.8) | – | 4 (4.2) | – | 1 (11.1) | – | – | – |
|
| 2 (25) | 22 (42.3)** | 23 (48.9)** | 24 (25.3) | – | 1 (11.1) | 2 (25) | 2 (25) | 2 (25) |
|
| – | 3 (5.8) | 1 (2.1) | 7 (7.4) | – | 1 (11.1) | – | – | – |
|
| 0* | 8 (15.4)** | 8 (17)** | 40 (42.1) | – | 0** | 0* | 0* | 0* |
|
| – | 2 (3.8) | 2 (4.3) | 1 (1.1)** | – | – | – | – | – |
|
| 2 (25) | 12 (23.1) | 9 (19.1) | 16 (16.8) | – | 5 (55.6)** | 2 (25) | 2 (25) | 2 (25) |
| NT | 4 (50)** | 3 (5.8) | 4 (8.5) | 3 (3.2) | 1 (100)** | 1 (11.1) | 4 (50)** | 4 (50)** | 4 (50)** |
| alp gene | |||||||||
| | 1 (12.5) | 8 (15.4)** | 8 (17)** | 40 (42.1) | 1 (100) | 1 (11.1) | 1 (12.5) | 1 (12.5) | 1 (12.5) |
| | 2 (25) | 20 (38.5)** | 21 (44.7)** | 22 (23.1) | – | 1 (11.1) | 2 (25) | 2 (25) | 2 (25) |
| | – | 9 (17.3) | 9 (19.1) | 16 (16.8) | – | – | – | – | – |
| | 3 (37.5) | 12 (23.1)* | 5 (10.6) | 13 (13.7) | – | 6 (66.7)** | 3 (37.5) | 3 (37.5) | 3 (37.5) |
| | – | – | – | – | – | – | – | – | – |
| | 2 (25)** | 2 (3.8) | 3 (6.4) | 3 (3.2) | – | 1 (11.1) | 2 (25) | 2 (25) | 2 (25) |
| | – | – | – | 0** | – | – | – | – | – |
| NT | – | 1 (1.9) | 1 (2.1) | 1 (1.1) | – | – | – | – | – |
* p < 0.05
** p < 0.01